|
1
|
Kamen DL: Environmental influences on
systemic lupus erythematosus expression. Rheum Dis Clin North Am.
40:401–412. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mu Q, Zhang H and Luo XM: SLE:Another
Autoimmune Disorder Influenced by Microbes and Diet? Front Immunol.
6:6082015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kamada N, Seo SU, Chen GY and Núñez G:
Role of the gut microbiota in immunity and inflammatory disease.
Nat Rev Immunol. 13:321–335. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hevia A, Milani C, López P, Cuervo A,
Arboleya S, Duranti S, Turroni F, González S, Suárez A, Gueimonde
M, et al: Intestinal dysbiosis associated with systemic lupus
erythematosus. MBio. 5:e01548–e14. 2014.doi: 10.1128/mBio.01548-14.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Vieira SM, Pagovich OE and Kriegel MA:
Diet, microbiota and autoimmune diseases. Lupus. 23:518–526. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Klack K, Bonfa E and Borba Neto EF: Diet
and nutritional aspects in systemic lupus erythematosus. Rev Bras
Reumatol. 52:384–408. 2012.PubMed/NCBI
|
|
7
|
Caetano MC, Ortiz TT, Terreri MT, Sarni
RO, Silva SG, Souza FI and Hilário MO: Inadequate dietary intake of
children and adolescents with juvenile idiopathic arthritis and
systemic lupus erythematosus. J Pediatr (Rio J). 85:509–515. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bruce IN: ‘Not only…but also’: Factors
that contribute to accelerated atherosclerosis and premature
coronary heart disease in systemic lupus erythematosus.
Rheumatology (Oxford). 44:1492–1502. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Oeser A, Chung CP, Asanuma Y, Avalos I and
Stein CM: Obesity is an independent contributor to functional
capacity and inflammation in systemic lupus erythematosus.
Arthritis Rheum. 52:3651–3659. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Katz P, Gregorich S, Yazdany J, Trupin L,
Julian L, Yelin E and Criswell LA: Obesity and its measurement in a
community-based sample of women with systemic lupus erythematosus.
Arthritis Care Res (Hoboken). 63:261–268. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Katz P, Yazdany J, Julian L, Trupin L,
Margaretten M, Yelin E and Criswell LA: Impact of obesity on
functioning among women with systemic lupus erythematosus.
Arthritis Care Res (Hoboken). 63:1357–1364. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yuen HK and Cunningham MA: Optimal
management of fatigue in patients with systemic lupus
erythematosus: A systematic review. Ther Clin Risk Manag.
10:775–786. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Reifen R, Amital H, Blank M, Sklan D,
Berkovich Z, Gershwin E and Shoenfeld Y: Linseed oil suppresses the
anti-beta-2-glycoprotein-I in experimental antiphospholipid
syndrome. J Autoimmun. 15:381–385. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
National Institutes of Health: National
Heart, Lung, and Blood Institute: Obesity education initiative.
Clinical guidelines on the identification, evaluation, and
treatment of overweight and obesity in adults: The evidence report.
Obes Res. 6:51S–209S. 1998.PubMed/NCBI
|
|
15
|
Rodríguez Huerta MD, Trujillo-Martín MM,
Rúa-Figueroa Í, Cuellar-Pompa L, Quirós-López R and Serrano-Aguilar
P: Spanish SLE CPG Development Group: Healthy lifestyle habits for
patients with systemic lupus erythematosus: A systemic review.
Semin Arthritis Rheum. 45:463–470. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Everett ST, Wolf R, Contento I, Haiduc V,
Richey M and Erkan D: Short-term patient-centered nutrition
counseling impacts weight and nutrient intake in patients with
systemic lupus erythematosus. Lupus. 24:1321–1326. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Borges MC, Santos FM, Telles RW, Correia
MI and Lanna CC: Polyunsaturated omega-3 fatty acids and systemic
lupus erythematosus: What do we know? Rev Bras Reumatol.
54:459–466. 2014.(In Portuguese). View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Halade GV, Rahman MM, Bhattacharya A,
Barnes JL, Chandrasekar B and Fernandes G: Docosahexaenoic
acid-enriched fish oil attenuates kidney disease and prolongs
median and maximal life span of autoimmune lupus-prone mice. J
Immunol. 184:5280–5286. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ierna M, Kerr A, Scales H, Berge K and
Griinari M: Supplementation of diet with krill oil protects against
experimental rheumatoid arthritis. BMC Musculoskelet Disord.
11:1362010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Petri M: Diet and systemic lupus
erythematosus: From mouse and monkey to woman? Lupus. 10:775–777.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Patavino T and Brady DM: Natural medicine
and nutritional therapy as an alternative treatment in systemic
lupus erythematosus. Altern Med Rev. 6:460–471. 2001.PubMed/NCBI
|
|
22
|
Leiba A, Amital H, Gershwin ME and
Shoenfeld Y: Diet and lupus. Lupus. 10:246–248. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Molfino A, Amabile MI, Monti M and
Muscaritoli M: Omega-3 polyunsaturated fatty acids in critical
illness: Anti-inflammatory, proresolving, or both? Oxid Med Cell
Longev. 2017:59870822017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Calder PC: Marine omega-3 fatty acids and
inflammatory processes: Effects, mechanisms and clinical relevance.
Biochim Biophys Acta. 1851:469–484. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
MilovanovIu S, Lysenko LV, Milovanova Ll
and Dobrosmyslov IA: The role of balanced low-protein diet in
inhibition of predialysis chronic kidney disease progression in
patients with systemic diseases. Ter Arkh. 81:52–57. 2009.
|
|
26
|
Brown AC: Lupus erythematosus and
nutrition: A review of the literature. J Ren Nutr. 10:170–183.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ritterhouse LL, Lu R, Shah HB, Robertson
JM, Fife DA, Maecker HT, Du H, Fathman CG, Chakravarty EF, Scofield
RH, et al: Vitamin D deficiency in a multiethnic healthy control
cohort and altered immune response in vitamin D deficient
European-American healthy controls. PLoS One. 9:e945002014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Antico A, Tampoia M, Tozzoli R and Bizzaro
N: Can supplementation with vitamin D reduce the risk or modify the
course of autoimmune diseases? A systematic review of the
literature. Autoimmun Rev. 12:127–136. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Solovastru LG, Vata D, Stătescu L,
Constantin MM and Andrese E: Skin cancer between myth and reality,
yet ethically constrained. Rev Rom Bioet. 12:47–52. 2014.
|
|
30
|
Kamen DL, Cooper GS, Bouali H, Shaftman
SR, Hollis BW and Gilkeson GS: Vitamin D deficiency in systemic
lupus erythematosus. Autoimmun Rev. 5:114–117. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Arnson Y, Amital H and Shoenfeld Y:
Vitamin D and autoimmunity: New aetiological and therapeutic
considerations. Ann Rheum Dis. 66:1137–1142. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wu PW, Rhew EY, Dyer AR, Dunlop DD,
Langman CB, Price H, Sutton-Tyrrell K, McPherson DD, Edmundowicz D,
Kondos GT, et al: 25-hydroxyvitamin D and cardiovascular risk
factors in women with systemic lupus erythematosus. Arthritis
Rheum. 61:1387–1395. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ben-Zvi I, Aranow C, Mackay M, Stanevsky
A, Kamen DL, Marinescu LM, Collins CE, Gilkeson GS, Diamond B and
Hardin JA: The impact of vitamin D on dendritic cell function in
patients with systemic lupus erythematosus. PLoS One. 5:e91932010.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hiraki LT, Munger KL, Costenbader KH and
Karlson EW: Dietary intake of vitamin D during adolescence and risk
of adult-onset systemic lupus erythematosus and rheumatoid
arthritis. Arthritis Care Res (Hoboken). 64:1829–1836. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ruiz-Irastorza G, Gordo S, Olivares N,
Egurbide MV and Aguirre C: Changes in vitamin D levels in patients
with systemic lupus erythematosus: Effects on fatigue, disease
activity, and damage. Arthritis Care Res (Hoboken). 62:1160–1165.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fragoso TS, Dantas AT, Marques CD, Rocha
Junior LF, Melo JH, Costa AJ and Duarte AL: 25-Hydroxyivitamin D3
levels in patients with systemic lupus erythematosus and its
association with clinical parameters and laboratory tests. Rev Bras
Reumatol. 52:60–65. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Stockton KA, Kandiah DA, Paratz JD and
Bennell KL: Fatigue, muscle strength and vitamin D status in women
with systemic lupus erythematosus compared with healthy controls.
Lupus. 21:271–278. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cuervo A, Hevia A, López P, Suárez A,
Sánchez B, Margolles A and González S: Association of polyphenols
from oranges and apples with specific intestinal microorganisms in
systemic lupus erythematosus patients. Nutrients. 7:1301–1317.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Terahara N: Flavonoids in foods: A review.
Nat Prod Commun. 10:521–528. 2015.PubMed/NCBI
|
|
40
|
Tantu M, Belu E, Bobescu E, Armean SM,
Armean P and Constantin MM: Domnariu CD6: Role of angiotensin
converting enzyme (ACE) inhibitors in hypertension and
cardiovascular protection management. Farmacia. 62:443–451.
2014.
|
|
41
|
Hull RP and Goldsmith DJ: Nephrotic
syndrome in adults. BMJ. 336:1185–1189. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hong YH, Huang CJ, Wang SC and Lin BF: The
ethyl acetate extract of alfalfa sprout ameliorates disease
severity of autoimmune-prone MRL-lpr/lpr mice. Lupus. 18:206–215.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Mannoor MK, Shimabukuro I, Tsukamotoa M,
Watanabe H, Yamaguchi K and Sato Y: Honeybee royal jelly inhibits
autoimmunity in SLE-prone NZB × NZW F1 mice. Lupus. 18:44–52. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Gupta SC, Patchva S and Aggarwal BB:
Therapeutic roles of curcumin: Lessons learned from clinical
trials. AAPS J. 15:195–218. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Schraufstatter E and Bernt H:
Antibacterial action of curcumin and related compounds. Nature.
164:456–457. 1949. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Aggarwal BB and Sung B: Pharmacological
basis for the role of curcumin in chronic diseases: An age-old
spice with modern targets. Trends Pharmacol Sci. 30:85–94. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Khajehdehi P, Zanjaninejad B, Aflaki E,
Nazarinia M, Azad F, Malekmakan L and Dehghanzadeh GR: Oral
supplementation of turmeric decreases proteinuria, hematuria, and
systolic blood pressure in patients suffering from relapsing or
refractory lupus nephritis: A randomized and placebo-controlled
study. J Ren Nutr. 22:50–57. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Belcaro G, Cesarone MR, Dugall M,
Pellegrini L, Ledda A, Grossi MG, Togni S and Appendino G:
Product-evaluation registry of Meriva®, a
curcumin-phosphatidylcholine complex, for the complementary
management of osteoarthritis. Panminerva Med. 52 (Suppl 1):55–62.
2010.PubMed/NCBI
|
|
49
|
Aggarwal BB, Gupta SC and Sung B:
Curcumin: An orally bioavailable blocker of TNF and other
pro-inflammatory biomarkers. Br J Pharmacol. 169:1672–1692. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Shpitz B, Giladi N, Sagiv E, Lev-Ari S,
Liberman E, Kazanov D and Arber N: Celecoxib and curcumin
additively inhibit the growth of colorectal cancer in a rat model.
Digestion. 74:140–144. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Căruntu C, Boda D, Musat S, Căruntu A and
Mandache E: Stress-induced mast cell activation in glabrous and
hairy skin. Mediators Inflamm. 2014:1059502014. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Raţiu MP, Purcărea I, Popa F, Purcărea VL,
Purcărea TV, Lupuleasa D and Boda D: Escaping the economic turn
down through performing employees, creative leaders and growth
driver capabilities in the Romanian pharmaceutical industry.
Farmacia. 59:119–13. 2011.
|
|
53
|
Olteanu R, Zota A and Constantin M:
Biosimilars: An Update on Clinical Trials (Review of Published and
Ongoing Studies). Acta Dermatovenerol Croat. 25:57–66.
2017.PubMed/NCBI
|
|
54
|
Olteanu R, Constantin MM and Zota A:
Original clinical experience and approach to treatment study with
interleukine 12/23 inhibitor in moderate-to-severe psoriasis
patients. Farmacia. 64:918–921. 2016.
|
